Summary. Fasting hypergtycaemia occurred in 48 h starved rats after 30 rain of anaesthesia with ether or halothane. Plasma insulin increased only with ether. I~alo-thane caused basal hyperglycaemia in fed rats, but decreased plasma insulin by 50O/o . Intravenous pentobarbitone (30 mg/kg) did not affect blood glucose in starved rats, but decreased plasma insulin with a small rise in blood glucose in fed rats. Following intravenous glucose (0.5 g/kg), hyperglycaemia and impaired glucose tolerance with normM insulin/glucose ratios occurred in starved animals anaesthetised with ether and pentobarbitone. The latter had no effect on glucose tolerance in fed rats. In contrast., hMothane caused hyperglycaemia without glueose intolerance in starved maimals, but decreased the insulin response by 400/0 in fed animals. Ketamine (30 rag/ kg) caused only a 15% increase in glucose area in starved rats and was otherwise without effect, ttalothane had no significant effect on glucose stimulated insulin secretion in the isolated perfused rat pancreas. --Possible mechanisms for these effects are discussed.
The effects of anaesthetic agents on carbohYdrate metabohsm in man and experimental animals have been widely studied since the original observation by geynoso [1] that glycosuria occurred during ether anaesthesia. Interpretation of human data is often complicated by the use of associated drugs for premedication, induction and maintenance of anaesthesia during surgical procedures [2] . In the rat recent work has shown that severM anaesthetic agent, s profoundly affect hepatic carbohydxate metabolism in vitro [3] and have a pronounced influence on blood metabolites and insulin in rive, the effects varying with dietary state [4] . However, few reports have been concerned with a direct comparison of the metabolic effects of different anaesthetic agents under carefully controlled experimental and dietary conditions, following an exogenous glucose load.
We report below the results of such a comparative study of the effects of ether, halothane, pentobarbitone sodium, and ketamine hydroehloride, on glucose tolerance and plasma insulin in starved and fed rats.
withdrawn 48 h before the intravenous glucose tolerance test.
Femoral vein and artery cannulae were inserted under light ether anaesthesia 16--20 h before testing, and kept patent with 0.1-0.2 ml saline containing 100 U/ml heparin as previously described [8] , the rats being placed in restraining cages until the experiment. Food consumption dropped slightly during the period of restraint (12 • 4 g compared with 20 ~ 4 g for unrestrained animals).
Experimental Design
Inhalation anaesthesia was commenced immediately after an initial arterial blood sample (0.3 ml) had been taken (--30 rain). Two further samples were taken at 15 rain intervals and then glucose (0.5 g/kg) injected intravenously in 15 see as a 50% (w/v) solution. Further arterial samples were taken at 1, 2.5, 5, 10, 20 and 30 rain after the end of the glucose injection, anaesthesia being maintained throughout.
For intravenous anaesthesia, samples were taken 30 min and 5 rain before glucose (--30 and --5 rain) with the anaesthetic injeeted immediately after the --5 rain sample. Control animals received an equivalent volume of saline at this point. A further blood sample was drawn before the glucose injection (time 0), with subsequent blood sampling as with the inhalational anaesthesia experiments.
Blood samples were processed as described previously
IS]"
Administration of Anaesthesia to Animals The inhalational agents (diethyl ether and halothane) were administered by passing a flow of pure oxygen (2 L/min) through the precision vaporizer and subsequently into a small exposure chamber into which the animal was placed, the rate of flow being sufficient to prevent any accumulation of CO2.
Sodium pentobarbitone and ketamine hydroehloride were given intravenously (30 mg/kg,) as 30 mg/ml solutions in 0.9% saline. The animals anaesthetised by the intravenous route, and the control unanaesthetised animals were also exposed to two litres of oxygen per minute in the exposure chamber during the experiments. In addition to providing identical experimental conditions, this procedure prevented the fall in rectal temperature following sodium pentobarbitone which was noted in preliminary experiments.
Isolated Perfused Rat Pancreas
The organ was isolated from fed rats and perfused according to the method of Sussman et al. [9] , using an Ambec perfusion unit (Beck Industries Inc. Boulder, Colo., U.S.A.). The perfusate was a mixture of Krebsl~inger bicarbonate solution containing 20% heparinised rat blood and 2.5% bovine albumin and was gassed with 95% oxygen and 5% carbon dioxide. Perfusion flow rate and pressure were kept at 2 ml/min and 40--60 mmI-Ig respectively. All the venous effluent was collected at timed intervals and assayed for immunoreactive insulin and glucose. IIalothane (2.5% v/v) was introduced into the circuit as described in the text. The changes in blood glucose were accompanied by significant increases in plasma insulin, particularly in the latter stages of the test ~4th no significant change in insulin to glucose ratio. This suggests hypergIycaemia secondary to decreased peripheral glucose uptake rather than decreased pancreatic responsiveness. b) Halothane. A significant rise in fasting blood glucose (3.9 to 4.9 mM; p < 0.01) occurred a.fter 30 rain of anaesthesia without a concurrent rise in plasma insulin (Fig. 1) . The response to glucose was, however, similar to that seen with the ether anaesthetised animals. Blood glucose values, glucose increment values (AG), ratios between the two groups, although insulin values tended to be higher than in controls. Thus pentobarbitone a.naesthesia caused glucose intolerance and hyperglycaemia despite appropriate insulin levels, due possibly to a defect in peripheral glucose assimilation. d) Ketamine hydrochloride. Ketamine had less effect on glucose and insulin than the three other anaesthetic agents tested in starved rats (Table 1 ). There was a 15% increase in total glucose area with ketamine hydrochloride (p < 0.05), although glucose disappea.rance, plasma insulin and insulin/glucose ratios were within normal limits. and total 30 min glucose area. were all significantly increased compared with controls (Table 1) . However, glucose disappearance was not affected (2.36 ~ 0.38%/ rain for the halothane group, 2.80~0.28%/min for controls). Plasma insulin was higher throughout but this achieved significance only at 20 and 30 rain after glucose. c) Sodium. pentobarbitone. No change in fasting blood glucose or plasma insulin occurred five minutes after induction of anaesthesia. Intravenous glucose tolerance was significantly decreased (1.674-0.29%/ rain compared with 2.80 ~= 0.28 %/min; p < 0.05), with a marked rise in total 30 rain glucose area {Table 1). There was no significant difference in insulin/glucose
Calculations

Blood Glucose, Plasma Insulin and Glucose Tolerance during A~,uesth~sia in Fed Rats
Unanaesthetised control fed animals showed improved glucose tolerance, a greater insulin response and higher basal blood glucose and plasma insulin than control 48 h starved animals. a) Halothane. In contrast to the starved situation there was a highly significant (50%) fall in plasma insulin 30 rain after induction of anaesthesia. This was accompanied by a small rise in blood glucose (Fig. 2) and was followed, after the glucose injection, by a blunted insulin response. The insulin values were comparable to those found in starved animals. Total 30 mill insulin area was significantly decreased, (1492 [xU m1-I30 min -1 compared with 2496 y.U m1-130 min -a for controls; p < 0.05) and total 30 rain glucose area increased. Thus insulin secretion was markedly suppressed in the fed animal, which must have contributed to the subsequent hyperglycaemia. (Fig. 2) . However, in contrast to halothane, intravenous injection of glucose resulted ha a.~l exaggerated peak insulin response, although there were no significant changes in blood glucose, total 30 rain glucose area and total insulin area. Glucose tolerance was unaffected in the fed animals in marked contrast to the glucose intolerance found in the starved state. Table 3 shows the effects of halothane on insulin secretion by the isolated perfused rat pancreas. After an initial 100 mg glucose pulse halothane (2.5 ~o v/v) was added to the 02/C02 mixture oxygenating the perfusion medium of the test pancreases. The two control pancreases had no halothane added. After a further 20 rain control period glucose was added to the medium giving a final concentration of 20 raM. I-Ialothane admi~fistration was stopped 20 min later. There were no significant difference between control and test perfusions except after the end of halothane, suggesting an "off-effect". However, the test perfusions had a higher response to the glucose pulse and on a percentage basis the late changes although still present were not significant. In these experiments 3.3 mM glucose was present throughout the early part of the perfusion. In two other perfusions where 3.3 mM glucose was omitted from the initial perfusion medium absolute insulin responses were much smaller. However when halothane was stopped during a subsequent 20 ml~{ glucose infusion there was again an "off-effect". The significance of this is unclear. There was no difference in arterial pressures between haIothane and eontroI perfusions.
The Effect of Halothane on Insulin Secretion by the Isolated Perfused Rat Pancreas
Discussion
Glucose intolerance during anaesthesia has been described in studies in man and experimental animals. In man, ether [11] , halothane [12, 13] , and pentobarbitone [14] cause intolerance to intravenous glucose. Interpretation of data from most human studies is complicated by the additional influences of drugs used for premedieation, induction and maintenance of anaesthesia. Studies in tile rat have shown intolerance to oral [15] , Subcutaneous [15] and intravenous [16] glucose under barbiturate anaesthesia. However, few studies have correlated changes in glucose metabolism with changes in plasma insulin response and dietary state, under the influence of different anaesthetic agents. The effects of ketamine hydrochloride on glucose tolerance and plasma insulin have also not been previously reported.
Both ether and halothane caused a rise in fasting blood glucose after thirty minutes of anaesthesia in the A. Aynsley-Green et al. : Anaesthesia and Insulin Secretion Diabetologia starved animal. This was accompanied by a rise in plasma insulin only in the ether group. In fed animals, there was a similar rise in basal blood glucose with halothane, but this time there was a highly significant decrease in plasma insulin. Bite and Eakins [17] have also shown this hyperglycaemie effect in rabbits. Different effects in fed and starved animals were also seen five minutes after induction of anaesthesia with pentobarbitone sodium. There was no effect in starved animals but glucose rose and plasma insulin fell in fed animals. Others have reported hyperglyeaemia in fed sodium anaesthesia, but were abolished in the fed group. In contrast, halothane did not cause glucose intolerance in starved animals despite increasing the total glucose area. However, plasma insulin although higher did not rise significantly above control values in the first ten minutes after glucose despite the hyperglycaemia. The decreased plasma insulin response is greatly accentuated in the fed group exposed to halothane where the total insulin area is only 60% of the control area. [18] but not in 24 h starved rats with similar doses of pentobarbitone [19] . Ketamine hydrochloride had no effect on fasting blood glucose or plasma insulin. Benke [19] also found no effect of ketamine in 24 h starved normal rats but interestingly noted a marked rise in glucose in alloxan diabetic rats.
Following the glucose injection ether, in starved animals, caused hyperglyeaemia and a marked decrease in glucose disappearance rate despite a normal insulin to glucose area ratio. Similar, but less pronounced, effects were seen in the starved group under pentobarbitone Ketamine hydroehloride had less effect than the other agents in starved animals, causing only a 15% increase in glucose area. Glucose disappearance rate and total insulin area were not affected, the total insulin area being appropriate for the slight rise in blood glucose.
The manifest effects of' anaesthesia in the whole animal are the result of a complex interaction of enzymatic, hormonal, cardiovascular and neurological mechanisms. The effects could be due to at least three mechanisms: changes in endocrine secretion, in the hepatic handling of glucose, and in the peripheral uptake of glucose.
The hyperglycaemic effect of ether has been said to be secondary to increased cateeholamine release [20] . It is unlikely that the rise in fasting blood glucose seen in the present study with ether and hMothane is due to this mechanism since hepatic glycogen stores are almost totally depleted after starvation, and Cori [21] has shown that glycogen stores must be present for this effect. It is more likely that these changes are due to factors affecting glucose utilisation. The fall in plasma in fed animals observed five minutes after administration, although it is not clear why this effect was not seen in starved animals.
Ether, halothane and pentobarbitone sodium all increase the blood levels of other hormones which could in turn affect plasma insulin and blood glucose. Both ether and halothane increase A.C.T.I-I. and cortisol levels in man [26, 27] , whilst pentobarbitone sodium, but not ether, stimulates growth hormone in the rat [28] . The importance of these hormones in the effects reported here is speculative. Number of perfusions given in parentheses. ]~esults • S.E.M. For % reponses the baseline sample immediately preceding the glucose pulse was taken as 100%.
insulin in fed animals and the decreased insulin response after glucose in both groups with halothane could be due to increased sympathetic activity since Porte et al. [22] have demonstrated decreased plasma insulin levels after epinephrine infusion. On the other hand Allison et al. [12] have shown that infusion of phentolamine in man did not prevent the decreased insulin response to glucose injected during halothane anaesthesia, and others have disputed whether halothane in fact elicits a sympathetic response [23, 24] . Our results from the perfused pancreas suggest that halothane does not have a direct inhibitory effect on insulin secretion from the pancreas. Other mechanisms of action must be sought.
Pentobarbitone sodium has been shown not to affect insulin secretion in vitro [25] but with this agent, eatecholamine induced inhibition of insulin release could be implicated to explain the fall in insulin levels
The influence of anaesthesia on hepatic function could also be involved. Ether [11] , halothane [3] and barbiturates [29] all affect hepatic enzymes involved in glucose homeostasis, and further, these enzymes are profoundly influenced by nutritional state [3] . In addition, hepatic blood flow has been shown to be decreased during anaesthesia in man [30, 31] which could affect clearance of glucose. Brunner [32] has demonstrated decreased uptake of glucose by skeletal muscle in vitro in the presence of ether whilst Merin [33] has suggested that halothane interferes with myocardial uptake of glucose. On the other hand, Davidson [16] demonstrated increased uptake of glucose by skeletal muscle in vitro in the presence of pentobarbitone.
In conclusion, the effects of halothane could be due to alterations in tissue blood flow and blood pressure although appropriate measurements were not performed in our study. The effects o~ ether and pento-barbitone sodium are probably due to effects on the hepatic and peripheral handling of glucose, together with changes in regional blood flow. The decrease in basal plasma insulin seen in fed animals anaesthetised with pentobarbitone sodium could be due to increased sympathetic activity, and the use of adrenergic blocking drugs or the direct measurement of plasma catecholamines may help resolve this.
The main implications of this study are that experimental data derived from glucose tolerance tests performed under anaesthesia should be interpreted in the light of the effects of the anaesthetic, and that such effects are dependent on nutritional status.
Similar studies in man may help the selection of the most suitable anaesthetic for patients in whom the metabolic effects of anaesthesia could be important. 
